IRIS
SANTORO, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.292
EU - Europa 11.844
AS - Asia 8.346
SA - Sud America 3.848
AF - Africa 231
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 15
Totale 38.594
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.949
SG - Singapore 3.642
BR - Brasile 3.373
IT - Italia 3.082
IE - Irlanda 2.294
CN - Cina 2.062
SE - Svezia 1.928
RU - Federazione Russa 1.199
HK - Hong Kong 1.029
DE - Germania 853
VN - Vietnam 585
UA - Ucraina 499
FI - Finlandia 470
NL - Olanda 379
GB - Regno Unito 313
IN - India 289
FR - Francia 239
PL - Polonia 191
AR - Argentina 176
CA - Canada 170
MX - Messico 112
BD - Bangladesh 96
TR - Turchia 87
EC - Ecuador 77
ZA - Sudafrica 73
ID - Indonesia 71
AT - Austria 67
IQ - Iraq 64
JP - Giappone 57
BE - Belgio 56
UZ - Uzbekistan 52
CO - Colombia 51
VE - Venezuela 51
ES - Italia 49
MA - Marocco 45
CZ - Repubblica Ceca 43
PK - Pakistan 41
PY - Paraguay 36
PE - Perù 27
RO - Romania 27
AZ - Azerbaigian 26
CI - Costa d'Avorio 25
CL - Cile 25
AE - Emirati Arabi Uniti 24
IL - Israele 24
UY - Uruguay 22
AL - Albania 20
CH - Svizzera 20
LT - Lituania 20
JO - Giordania 19
EG - Egitto 18
KE - Kenya 17
NP - Nepal 17
IR - Iran 16
KG - Kirghizistan 16
KZ - Kazakistan 16
TN - Tunisia 16
DO - Repubblica Dominicana 15
DZ - Algeria 15
GR - Grecia 15
BG - Bulgaria 11
PS - Palestinian Territory 11
AU - Australia 10
EU - Europa 10
GE - Georgia 10
JM - Giamaica 10
BO - Bolivia 9
KR - Corea 9
LB - Libano 9
OM - Oman 9
SA - Arabia Saudita 9
NO - Norvegia 8
RS - Serbia 8
BY - Bielorussia 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
PA - Panama 7
SN - Senegal 7
AM - Armenia 6
EE - Estonia 6
GT - Guatemala 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
BN - Brunei Darussalam 5
HN - Honduras 5
LK - Sri Lanka 5
MD - Moldavia 5
NI - Nicaragua 5
PH - Filippine 5
PT - Portogallo 5
TJ - Tagikistan 5
CR - Costa Rica 4
CY - Cipro 4
GA - Gabon 4
LU - Lussemburgo 4
MY - Malesia 4
SV - El Salvador 4
TH - Thailandia 4
XK - ???statistics.table.value.countryCode.XK??? 4
DK - Danimarca 3
Totale 38.551
Salva come PNG Salva come JPEG
Città #
Dublin 2.291
Dallas 2.087
Singapore 1.694
Ashburn 1.600
Chandler 1.588
Jacksonville 1.097
Hong Kong 1.026
Nyköping 959
Beijing 935
Princeton 426
Medford 392
Los Angeles 379
Messina 371
Cambridge 359
Dearborn 354
Des Moines 316
Moscow 313
The Dalles 297
Oude Meer 278
São Paulo 274
New York 256
Boardman 251
Ann Arbor 243
Munich 219
Buffalo 214
Ho Chi Minh City 195
Rome 187
Warsaw 170
Hyderabad 146
Milan 146
Hanoi 134
San Mateo 120
Redondo Beach 115
Rio de Janeiro 102
Woodbridge 102
Belo Horizonte 100
Jinan 99
Wilmington 95
Tianjin 91
Houston 88
Turku 75
Bremen 73
Shenyang 66
Frankfurt am Main 64
Brasília 61
Catania 61
Palermo 60
Seattle 60
Brooklyn 56
Montreal 55
Nanjing 55
Brussels 53
Denver 51
Tokyo 51
Pune 50
Curitiba 49
Tashkent 48
Nuremberg 47
Stockholm 47
Ottawa 46
Porto Alegre 46
Santa Clara 45
Helsinki 44
Johannesburg 43
Hebei 41
Orem 40
Campinas 39
Vienna 39
Genova 38
London 38
Florence 37
Poplar 36
Chennai 35
Lancaster 34
Zhengzhou 33
Boston 32
Düsseldorf 32
Guangzhou 32
Hangzhou 32
Mexico City 32
Ningbo 32
Norwalk 32
Turin 32
Brno 31
Haikou 31
Bologna 30
Jakarta 30
Salvador 30
Chicago 29
Guarulhos 29
Caxias do Sul 28
Dong Ket 28
Guayaquil 27
Taizhou 27
Baku 26
Manaus 26
Naples 26
Napoli 26
Phoenix 26
Quito 26
Totale 22.557
Salva come PNG Salva come JPEG
Nome #
La sindrome MIA ( malnutrizione-infiammazione-aterosclerosi nel paziente uremico 1.474
Amiloidosi renale e fibrosi cistica: Ruolo della terapia con colchicina 683
Terapia nutrizionale nell'IRC in fase conservativa: suggerimenti di pratica clinica e di applicazione delle linee guida 400
Henoch-Schonlein purpura associated with acetaminophen and codeine. 356
Impotence in the XVIII century as described by Gian Pietro Fusanacci and Tommaso Eduardo Beatty 261
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 192
[Periorbital purpura: a pathognomonic but late sign of AL amyloidosis] / Porpora periorbitaria: un segnale patognomonico ma tardivo di amiloidosi AL 179
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 177
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 177
[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease] 168
Flavocoxid, a Natural Antioxidant, Protects Mouse Kidney from Cadmium-Induced Toxicity. 168
[Management of hyperphosphatemia in patients with chronic kidney disease] 167
A new approach to the evaluation of hyperphosphatemia in chronic kidney disease 166
[From hyponatremia to tolvaptan] 166
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 160
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 154
Association of higher advanced oxidation protein  products (AOPPs) levels in patients with diabetic  and hypertensive nephropathy 154
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 150
[Renal and extra-renal involvement in sclerodermia.] 150
Association of VDR gene polymorphisms with heart disease in chronic kidney disease patients 147
Sclerostin levels in uremic patients: a link between bone and vascular disease 145
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 144
Defense mechanisms in hemodialysis-dependent patients 141
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 141
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure 139
An update on calcium metabolism alterations and cardiovascular risk in patients with chronic kidney disease: questions, myths and facts. 138
Adaptation of the Mishel Uncertainty of Illness Scale (MUIS) for chronic patients in Italy 138
Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells 137
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 137
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 136
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 136
ALTERAZIONI RENALI IN UN CASO DI CRIOGLOBULINEMIA MISTA DI TIPO 2 IN UN PAZIENTE AFFETTO DA LINFOMA CON CELLULE B. 133
Association of parathyroid carcinoma and thyroid disorders: A clinical review 133
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 132
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 132
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 132
Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination 129
Absorbable phosphate in medication 126
History of L-carnitine: Implications for renal disease 125
A prospective, multicenter, randomized, controlled study: the Correction of Metabolic Acidosis with Use of Bicarbonate in Chronic Renal Insufficiency (UBI) Study 125
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 125
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy 123
Beneficial effects of oral pure caffeine on oxidative stress 123
Impotence in the 18th and 19th century: concepts of etiology and approaches to therapy. 122
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 122
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 122
Stress ossidativo in una popolazione di ipertesi e nefropatici: utilità del dosaggio dell’AOPP 120
The concept of the urine test and specific reaction of the urine in various diseases according to Enrico Cauchi - member of the medical council of Malta (1933) 119
Endothelial dysfunction in chronic renal failure. 118
Compliance ed emozioni in una popolazione di emodializzati 117
Kidney disease and psoriasis: novel evidences beyond old concepts 117
[From scientific evidence to clinical recommendations: outlooks and challenges for the SIN (Italian Society of Nephrology)] 117
A longitudinal study of sleep disorders in early-stage chronic kidney disease 116
C3 glomerulopathy in cystic fibrosis: a casereport 116
Autonomic dysfunction in uremia 114
EFFECTIVENESS OF L-CARNITINE THERAPY IN UREMIC ANEMIA 114
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 113
Pain in Renal Disease. 113
Nephro-oncology: a link in evolution 113
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 113
The Myth of Water and Salt: From Aquaretics to Tenapanor 113
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 113
Analisi dei costi dell’eritropoietina in dialisi nella regione sicilia 112
Vascular access for hemodialysis: current perspectives 112
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 112
Meccanismi di difesa in soggetti sottoposti a trattamento dialitico cronico 111
A Delphi consensus panel on nutritional therapy in chronic kidney disease 111
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 111
TERAPIA DELLE GLOMERULONEFRITI A LESIONI ISTOLOGICHE MINIME 110
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study 110
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 110
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 110
Compliance ed emozioni in una popolazione di emodializzati. 109
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 109
Kidney-lung connections in acute and chronic diseases: current perspectives 109
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 108
A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy 108
Caso clinico di una bambina con lichen follicolare e sindrome nefrosica 107
il Registro regionale siciliano di dialisi e trapianto 1997-1998:dati preliminari 107
ACUTE PARICALCITOL ADMINISTRATION REDUCE INFLAMMATION IN CKD PATIENTS IN VIVO AND IN VITRO 107
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 107
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 107
Expert opinion of nephrologists about the effectiveness of low-protein diet in different stages of chronic kidney disease (CKD) 106
Ruolo dell’attività fisica nei riguardi dello stato nutrizionale e dellinsorgenza di diabete mellito de-novo in pazienti nefrotrapiantati 106
Monoclonal antibodies for renal diseases: current concepts and ongoing treatments 106
[Anti-SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases. Recommendations of the Italian Society on Nephrology's Working Group on Renal Immunopathology (Vaccine Task Force)] 106
Erectyle dysfunction in uremic dialysis patients : diagnostic evaluation in the sildenafil era 105
Choice of dialysis treatment and type of medical unit (private vs public): application of a recursive bivariate probit 105
Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system 105
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 105
Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease 105
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 105
Cross-sectional evaluation of kidney function in hospitalized patients: estimated GFR versus renal scintigraphy 105
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 104
Extracellular Matrix Abnormality May be resposible for Cyst Development 103
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 102
Vitamin D receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease 102
Copy number variant analysis and genome-wide association study identify loci with large effect for vesicoureteral reflux 102
TGF-beta ed ADPKD. Studio immunoistochimico al CLSM 101
Modulazione dei dosaggi di EPO in terapia carnitinica 101
Totale 14.992
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.436
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.070 0 0 0 0 0 213 62 170 79 265 141 140
2021/20223.009 56 183 123 147 109 51 203 150 128 490 402 967
2022/20236.679 560 525 310 470 508 640 103 386 2.811 75 201 90
2023/20242.054 175 289 152 146 170 368 41 129 33 204 59 288
2024/20258.863 138 62 193 465 385 350 334 1.928 2.176 563 840 1.429
2025/202611.485 1.273 1.784 2.551 2.138 2.314 1.425 0 0 0 0 0 0
Totale 39.374